drugset / Trial / NCT04626778
Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the anti-bacterial, pre-procedural, clinical efficacy of Peroxyl mouthwash (1.5% hydrogen peroxide) in saliva and the reduction of bioaerosol contamination as compared to a matching placebo mouthwash (0.0% hydrogen peroxide)
Timeline
- Start
- 2020-10-08
- Primary completion
- 2020-12-15
- Completion
- 2020-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrogen Peroxide | Small molecule | 1.5 % | Topical |
Indications
No indication recorded.